" Ozempic face " is a common term used to describe the loss of facial fullness often seen after rapid weight loss with GLP1 receptor agonists ( semaglutide , tirzepatide , dulaglutide , etc.)
More importantly, have you developed sustainable habits that you can maintain without the medication's help
Unfused albumin variants or GLP-1 albumin fusions (2 mg/mL) were loaded onto the column in a pH gradient from pH 5.5 to pH 8.8 by injecting a gradual mixture of 20 mM MES/HCl, 140 mM NaCl (Sigma-Aldrich) (pH 5.5) and 20 mM Tris/HCl, 140 mM NaCl (Sigma-Aldrich) (pH 8.8) at a flow rate of 0.5 mL/min for 110 min at room temperature
Observational analyses and randomized clinical trials consistently report nausea, vomiting, diarrhea, constipation, and abdominal discomfort as the most common symptoms, although the distribution of events varies
GLP-1 Analogue Induced AKI
These are warning signs, not solutions